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Clinics and pathology 
Disease 
T-cell acute lymphoblastic leukemia (T-ALL). 
Epidemiology 
In only one case of t(5;14)(q35;q11) was the 
involvement of NKX2-5 and TRD ascertained. It was 
the case of a 3-year-old male patient with a common T-
ALL, herein described (Przybylski et al., 2006). 
Another case of t(5;14)(q35;q11), but without NKX2-
5-TRD ascertainement, is the case of a 45-year-old 
male patient with an acute monoblastic leukemia (FAB 
type M5). In this second case, the t(5;14) appears to be 
secondary to a t(6;11)(q27;q23). Although molecular 
studies were not available at that time, it is likely that 
the patient, who have had a history of possible toxic 
exposure, who presented with a high blood count 
(above 50X109/l), and who did not enter complete 
remission, had a MLL-MLLT4 hybrid gene (Welborn 
et al., 1993). 
Genes involved and proteins 
TRD 
Protein 





Homeodomain protein; belongs to the NK2/NKX 
family. Transcriptional activator; regulates beta-catenin 
and GATA4 in human cardiomyocytes (Riazi et al., 
2009). Involved in cardiac morphogenesis. NKX2-5 
mutations may cause congenital heart diseases, 
although it does not appear to be the main aetiologic 
factor (Draus et al., 2009). 




The break on chromosome 5 occurred between NKX2-
5 and BNIP1, and downstream the D3 diversity 
segment of TRD on chromosome 14. NKX2-5 was 
placed under influence of the TRD enhancer, resulting 
in strong ectopic NKX2-5 expression. 
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